Kevin Madoch

Kevin Madoch is an experienced Oncology Territory Business Manager at SpringWorks Therapeutics since February 2023. Prior to this role, Kevin served as Associate Director of Oncology Epigenetic Therapy at Epizyme from March 2020 to January 2023 and amassed 21 years of tenure at Pfizer Pharmaceuticals, where Kevin held the position of Senior Oncology Representative. With 13 years of focused Oncology sales experience, Kevin successfully launched multiple cancer drugs, including Ibrance, Xalkori, Sutent, Inlyta, Bosulif, and Talzenna, targeting various cancers such as Renal Cell, Breast Cancer, Colorectal Cancer, Lung Cancer, and Chronic Myeloid Leukemia. Kevin has received numerous awards, including two VPCs in Oncology, recognizing performance in the top 10%. Kevin holds a Bachelor of Science degree in Education from Illinois State University, obtained between 1988 and 1992.